Abcellute provides non-cryogenic cell preservation technology for the preservation and storage of fresh primary liver cells.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: London
State: England
Zip:
Country: United Kingdom
Abcellute is to achieve global adoption of its SureCellâ„¢ cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximise the utilisation of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2007 | Funding Round | 2 | $807.3k |
Development Bank of Wales Fusion IP Development Bank of Wales Fusion IP |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|